Kalyan Dulla - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Kalyan Dulla

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Molecular Therapy. Nucleic Acids|August 17, 2018

Splice-Modulating Oligonucleotide QR-110 Restores CEP290 mRNA and Function in Human c.2991+1655A>G LCA10 ModelsKalyan Dulla, Monica Aguila, Amelia Lane, et al.

American Journal of Human Genetics|March 13, 2018

Antisense Therapy for a Common Corneal Dystrophy Ameliorates TCF4 Repeat Expansion-Mediated ToxicityChristina Zarouchlioti, Beatriz Sanchez-Pintado, Nathaniel J Hafford Tear, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|April 25, 2021

Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by USH2A exon 13 mutationsKalyan Dulla, Ralph Slijkerman, Hester C van Diepen, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Molecular Therapy. Nucleic Acids|August 17, 2018

Splice-Modulating Oligonucleotide QR-110 Restores CEP290 mRNA and Function in Human c.2991+1655A>G LCA10 ModelsKalyan Dulla, Monica Aguila, Amelia Lane, et al.

American Journal of Human Genetics|March 13, 2018

Antisense Therapy for a Common Corneal Dystrophy Ameliorates TCF4 Repeat Expansion-Mediated ToxicityChristina Zarouchlioti, Beatriz Sanchez-Pintado, Nathaniel J Hafford Tear, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|April 25, 2021

Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by USH2A exon 13 mutationsKalyan Dulla, Ralph Slijkerman, Hester C van Diepen, et al.

Pageof 2